Dec 25, 2025 • Investing.com Nigeria
BULLISH
Sotera Health Co stock hits 52-week high at $17.79 By Investing.com
Sotera Health Co (SHC) stock has reached a new 52-week high of $17.79, reflecting a 28.49% increase over the past year and a 54.89% return in six months. This surge is supported by strong investor confidence, positive market conditions, and a "GOOD" financial health score, with analysts anticipating net income growth. The company also recently reported strong Q3 2025 financial results, exceeding analyst expectations, and announced a secondary offering.
Dec 25, 2025 • Sahm
BULLISH
Why Sotera Health (SHC) Is Up 5.3% After Margin-Beating Quarter Signals Efficiency Gains
Sotera Health (SHC) saw its stock rise by 5.3% after reporting a strong quarter with revenues up 9.1% year-on-year, beating analyst estimates, and achieving double-digit adjusted EBITDA growth alongside 150 basis points of margin expansion. These results highlight significant efficiency gains in its sterilization and lab testing operations. Despite these improvements, the company still faces risks related to ongoing ethylene oxide (EO) regulation and legal exposure, which management is addressing through elevated capital expenditure.
Dec 24, 2025 • Investing.com
SOMEWHAT-BULLISH
Sotera Health Co stock hits 52-week high at $17.79
Sotera Health Co's stock reached a new 52-week high of $17.79, reflecting strong investor confidence and positive market conditions. The company has seen significant stock price increases over the past year and six months, with analysts expecting net income growth. Recent news also highlights strong Q3 2025 financial results and positive analyst ratings.
Dec 24, 2025 • MarketBeat
NEUTRAL
Sotera Health Company (NASDAQ:SHC) Given Average Rating of "Moderate Buy" by Brokerages
Sotera Health Company (NASDAQ:SHC) has received an average "Moderate Buy" rating from seven brokerages, with a mean 12-month price target of $17.80. This sentiment comes despite significant insider selling totaling approximately $471.8 million in the last three months, though insiders still hold a substantial 55.12% of the stock. The company recently surpassed Q3 earnings expectations and provided optimistic FY2025 guidance.
Dec 19, 2025 • 富途牛牛
BULLISH
William Blair Initiates Sotera Health Company(SHC.US) With Buy Rating
William Blair analyst Max Smock has initiated coverage on Sotera Health Company (SHC.US) with a 'buy' rating. Smock has a 68.2% success rate and a 6.7% average return over the past year, according to TipRanks data. The rating reflects a positive outlook on Sotera Health Company's stock performance.
Dec 18, 2025 • Benzinga
BULLISH
Sotera Health Looks Undervalued, Analyst Says - Sotera Health (NASDAQ:SHC)
William Blair initiated coverage on Sotera Health (NYSE: SHC) with an Outperform rating, noting the company appears undervalued despite its strong market position and best-in-class margins. The analyst believes easing ethylene oxide litigation risks and improving free cash flow will lead to a re-rating of the stock, predicting approximately 45% upside over the next two years. Sotera Health's integrated sterilization platform and sticky customer base are highlighted as key strengths.